Ganciclovir release rates in vitreous from different formulations of 1-O-hexadecylpropanediol-3-phospho-ganciclovir

Journal of Ocular Pharmacology and Therapeutics

Volumn 19, Issue 2, 2003, Pages 161-169

  Cheng, Lingyun ^a,b   Hostetler, Karl Y ^a,b   Toyoguchi, Mitsuko ^a,b   Beadle, James R ^a,b   Rodanant, Nuttawut ^a,b   Gardner, Michael F ^a,b   Aldern, Kathy A ^a,b   Bergeron Lynn, Germaine ^a,b   Freeman, William R ^a,b  

^a VA Medical Center and UCSD ^*

^b UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1 O HEXADECYLPROPANEDIOL 3 PHOSPHOGANCICLOVIR; GANCICLOVIR; LIPOSOME; PRODRUG; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG RELEASE; DRUG TISSUE LEVEL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; NONHUMAN; RABBIT; TISSUE DISTRIBUTION; VITREOUS BODY;

EID: 0037965973     PISSN: 10807683     EISSN: None     Source Type: Journal    
DOI: 10.1089/108076803321637690     Document Type: Article

References (13)

1. Martin, D.F.; Ferris, F.L.; Parks,D. J.; Walton, R.C.; Mellow, S.D.; Gibbs, D.; Remaley, N. A.; Ashton, P.; Davis, M.D.; Chan, C.C. and Nussenblatt, R.B. Ganciclovir implant exchange. Timing, surgical procedure, and complications. Arch Ophthalmol, 115(11): 1389-1394, 1997.
2. Peyman, G.A.; Schulman, J.A.; Khoobehi, B.; Alkan, H.M.; Tawakol, M.E. and Mani, H. Toxicity and clearance of a combination of liposome-encapsulated ganciclovir and trifluridine. Retina, 9(3):232-236, 1989.
3. Peyman, G.A.; Conway, M.; Khoobehi, B. and Soike, K. Clearance of microsphere-entrapped 5-fluorouracil and cytosine arabinoside from the vitreous of primates. Int Ophthalmol, 16(2):109-113, 1992.
4. Giordano, G.G.; Refojo, M. F.; Arroyo, M. H.; and M.H. Arroyo. Sustained delivery of retinoic acid from microspheres of biodegradable polymer in PVR. Invest Ophthalmol Vis Sci, 34(9):2743-2751, 1993.
5. Danis, R.P.; Ciulla, T. A.; Pratt, L. M. and Anliker, W. Intravitreal triamcinolone acetonide in exudative age-related macular degeneration. Retina, 20(3):244-250, 2000.
6. Cheng, L.; Hostetler, K. Y.; Chaidhawangul, S.; Garder, M.F.; Beadle, J.R.; Keefe, K. S.; Bergeron-Lynn, G.; Severson, G. M.; Soules, K. A.; Mueller, A. J. and Freeman, W. R. Intravitreal toxicology and duration of efficacy of a novel antiviral lipid prodrug of ganciclovir in liposome formulation. Invest Ophthalmol Vis Sci, 41(6):1523-1532, 2000.
7. Merodio, M.; Irache, J. M.; Valamanesh, F. and Mirishahi, M. Ocular disposition and tolerance of ganciclovir-loaded albumin nanoparticles after intravitreal injection in rats. Biomaterials, 23(7):1587-1594, 2002.
8. Cheng, L.; Hostetler, K. Y.; Gardner, M. F.; Avila, C. P. Jr.; Bergeron-Lynn, G.; Keefe, K. S.; Wiley, C. A. and Freeman, W. R. Intravitreal toxicology in rabbits of two preparations of 1-O-octadecyl-sn-glycerol-3-phosphonoformate, a sustained-delivery anti-CMV drug. Invest Ophthalmol Vis Sci, 40(7):1487-1495, 1999.
9. Akula, S.K.; Ma, P. E.; Peyman, G. A.; Rahimy, M. H.; Hyslop, N. E. Jr.; Janney, A. and Ashton, P. Treatment of cytomegalovirus retinitis with intravitreal injection of liposome encapsulated ganciclovir in a patient with AIDS. Br J Ophthalmol, 78(9):677-680, 1994.
10. Besen, G.; Flores-Aguilar, M.; Assil, K. K.; Kupperman, B. D.; Gangan, P.; Pursley, M.; Munguia, D.; Voung, C.; De Clercq, E.; Bergeron-Lynn, G.; Stanley P. Azen and Freeman, W. R. Long-term therapy for herpes retinitis in an animal model with high-concentrated liposomeencapsulated HPMPC. Arch Ophthalmol, 113(5):661-668, 1995.
11. Shakiba, S.; Freeman, W. R.; Flores-Aguilar, M.; Munguia, D.; Tatebayashi, M.; Besen, G.; Amani, R.; Wiley, C. A.; Voung, C.; Aldern, K. A.; Gardner, M. F. and Hostetler, K. Y. Antiviral effect in human cytomegalovirus-infected cells, pharmacokinetics, and intravitreal toxicology in rabbits of acyclovir diphosphate dimyristoylglycerol. Antimicrob Agents Chemother, 39:1383-1385, 1995.
12. Cheng, L.; Chaidhawangul, S.; Gardner, M. F.; Beadle, J. R.; Toyoguchi, M.; Bergeron-Lynn, G.; Freeman, W. R. Treatment or prevention of herpes simplex virus retinitis with intravitreally injectable crystalline 1-O-hexadecylpropanediol-3-phospho-ganciclovir. Invest Ophthalmol Vis Sci. 43(2):515-21, 2002.
13. Cheng, L.; Hostetler, K. Y.; Gardner, M. F.; Avila, C. P. Jr.; Bergeron-Lynn, G.; Severson, G. M. and Freeman, W. R. Intravitreal pharmacokinetics in rabbits of the foscarnet lipid prodrug: 1-O-octadecyl-sn-glycerol-3-phosphonoformate (ODG-PFA). Curr Eye Res, 18(3):161-167, 1999.